Healthcare News

Deferasirox Market Size, Share, Growth, Trends, Analysis and Worldwide Forecast 2019-2025

Press Release

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.

The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood. Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.

Download Free PDF Sample Request: http://www.acutemarketreports.com/request-free-sample/128376

The global Deferasirox market is valued at 2270 million US$ in 2018 and will reach 3230 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Deferasirox market based on company, product type, end user and key regions.

This report studies the global market size of Deferasirox in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Deferasirox in these regions.

This research report categorizes the global Deferasirox market by top players/brands, region, type and end user. This report also studies the global Deferasirox market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Novartis
Cipla
Sun Pharma
Natco Pharma

Market size by Product

500 mg/Tablet
250 mg/Tablet
125 mg/Tablet
Others

Browse the full report at http://www.acutemarketreports.com/report/deferasirox-market

Market size by End User

Transfusional Iron Overload
NTDT Caused Iron Overload

Market size by Region

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:

To study and analyze the global Deferasirox market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Deferasirox market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Deferasirox companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Deferasirox submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Deferasirox are as follows:

History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Tablets). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Deferasirox market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Download Free PDF Sample Request: http://www.acutemarketreports.com/request-free-sample/128376

About Us

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Media Contact

Name: Chris Paul

Toll Free (US/CANADA): +1-855-455-8662 

Email: [email protected]

Website: http://www.acutemarketreports.com